In what might be viewed as unfortunate vindication for those who warned of the potential risks of rapidly-developed, one-size-fits-all COVID-19 vaccine policy, scientists have now suggested that the AstraZeneca jab used in many parts of the world may result in heightened risk of the neurological condition known as Guillain-Barre Syndrome (GBS), as the U.K. Telegraph reports.
Researchers at University College London discovered an increase in the incidence of GBS within a period of two to four weeks of receipt of the AstraZeneca jab, a phenomenon not seen following vaccination with the Pfizer or Moderna formulations.
It is thought that the specific manner in which the vaccine itself delivers its protective qualities may responsible for the enhanced level of risk, and it is also possible that the revelation may also be applicable to similar shots for tuberculosis, malaria, HIV, and other pathogens.
The AstraZeneca shot works by delivering the viral spike protein through a weakened chimp-derived adenovirus, and scientists suspect that it is a reaction to that mode of operation that could be causing GBS cases in higher numbers.
Professor Michael Lunn, lead author of the University College London study, stated, “It may be that a non-specific immune activation in susceptible individuals occurs, but if that were the case similar risks might apply to all vaccine types. It is therefore logical to suggest that the simian adenovirus vector, often used to develop vaccines, including AstraZeneca’s, may account for the increased risk.”
As the U.K. Mirror notes, GBS is an extremely rare affliction in which the body’s immune system goes to work attacking the nerves, often resulting in profound pain and numbness in the muscles, sometimes producing an inability to swallow and even breathe.
In the most dire GBS cases, sufferers can fall into what is known as “locked-in syndrome” whereby they stay completely conscious, but lose the ability to move any area of the body.
According to data from the Mayo Clinic, though the majority of patients impacted by GBS ultimately recover, anywhere between 4% and 7% of individuals with the syndrome will die from it, and while between 60% and 80% of individuals afflicted by the illness will be able to walk after six months, there are those who will have ongoing effects including fatigue, weakness, and numbness.
Even if it is scientifically established that COVID-19 jabs are causing serious harm to those who accepted them – either willingly or through government coercion – the unwillingness of public health officials to acknowledge and compensate vaccine injured individuals both here and abroad, does not bode well for widespread accountability for those who attempted to push shots on just about everyone.